Samuel Broder

543 total citations
12 papers, 456 citations indexed

About

Samuel Broder is a scholar working on Infectious Diseases, Virology and Immunology. According to data from OpenAlex, Samuel Broder has authored 12 papers receiving a total of 456 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Infectious Diseases, 6 papers in Virology and 3 papers in Immunology. Recurrent topics in Samuel Broder's work include HIV/AIDS drug development and treatment (8 papers), HIV Research and Treatment (6 papers) and HIV/AIDS Research and Interventions (3 papers). Samuel Broder is often cited by papers focused on HIV/AIDS drug development and treatment (8 papers), HIV Research and Treatment (6 papers) and HIV/AIDS Research and Interventions (3 papers). Samuel Broder collaborates with scholars based in United States, Switzerland and Poland. Samuel Broder's co-authors include Hiroaki Mitsuya, J. E. Karp, Robert Yarchoan, Robert Yarchoan, Thomas R. Webb, Shuzo Matsushita, Jane B. Trepel, Jeffrey Cossman, H Mitsuya and M Robert-Guroff and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Nucleic Acids Research and Hepatology.

In The Last Decade

Samuel Broder

12 papers receiving 435 citations

Peers

Samuel Broder

ID

VIROL

MB

IMMUN

EPIDE

LEOTA HALL United States

Bruce L. Booth United Kingdom

Alba Ruiz Spain

Tatiana Zavorotinskaya United States

Parvin S. Ahmed United Kingdom

S Broder United States

Joanne Yetz United States

Bipin C. Dash United States

Mohammed F. Rabbi United States

Katsuhiro Io Japan

LEOTA HALL United States

Samuel Broder

229 ×1.2

ID

398 ×2.4

VIROL

139 ×1.0

MB

134 ×1.2

IMMUN

142 ×1.5

EPIDE

Citations per year, relative to Samuel Broder Samuel Broder (= 1×) peers LEOTA HALL

Countries citing papers authored by Samuel Broder

Since Specialization

Citations

This map shows the geographic impact of Samuel Broder's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Samuel Broder with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Samuel Broder more than expected).

Fields of papers citing papers by Samuel Broder

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Samuel Broder. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Samuel Broder. The network helps show where Samuel Broder may publish in the future.

Co-authorship network of co-authors of Samuel Broder

This figure shows the co-authorship network connecting the top 25 collaborators of Samuel Broder. A scholar is included among the top collaborators of Samuel Broder based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Samuel Broder. Samuel Broder is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

12 of 12 papers shown

1.

Karp, Judith E. & Samuel Broder. (1992). The Pathogenesis of AIDS Lymphomas: A Foundation for Addressing the Challeng of Therapy and Prevention. Leukemia & lymphoma. 8(3). 167–188. 10 indexed citations

2.

Huryn, Donna M., S. Y. K. TAM, Iain S. Sim, et al.. (1992). Synthesis and anti-HIV activity of isonucleosides. Journal of Medicinal Chemistry. 35(13). 2347–2354. 53 indexed citations

3.

Fried, Michael, Adrian M. Di Bisceglie, Yoon Park, et al.. (1992). A Pilot Study of 2′,3′–Dideoxyinosine for the Treatment of Chronic Hepatitis B. Hepatology. 16(4). 861–864. 32 indexed citations

4.

Karp, J. E. & Samuel Broder. (1991). Acquired immunodeficiency syndrome and non-Hodgkin's lymphomas.. PubMed. 51(18). 4743–56. 67 indexed citations

5.

Broder, Samuel & Robert Yarchoan. (1990). Dideoxycytidine: Current clinical experience and future prospects. The American Journal of Medicine. 88(5). S31–S33. 9 indexed citations

6.

Yarchoan, Robert, Hiroaki Mitsuya, & Samuel Broder. (1990). Immunologic issues in anti-retroviral therapy. Immunology Today. 11(9). 327–333. 8 indexed citations

7.

Iyer, Radhakrishnan P., Bogdan Uznański, C. B. Storm, et al.. (1990). Abasic oligodeoxyribonucleoside phosphorothioates: synthesis and evaluation as anti-HIV-1 agents. Nucleic Acids Research. 18(10). 2855–2859. 18 indexed citations

8.

Yarchoan, Robert, Hiroaki Mitsuya, & Samuel Broder. (1989). Clinical and basic advances in the antiretroviral therapy of human immunodeficiency virus infection. The American Journal of Medicine. 87(2). 191–200. 26 indexed citations

9.

Ranki, Annamari, Robert Yarchoan, Samuel Broder, et al.. (1989). T-cell response towards HIV in infected individuals with and without zidovudine therapy, and in HIV-exposed sexual partners. AIDS. 3(2). 63–70. 65 indexed citations

10.

Yarchoan, Robert & Samuel Broder. (1989). Anti-retroviral therapy of AIDS and related disorders: General principles and specific development of dideoxynucleosides. Pharmacology & Therapeutics. 40(3). 329–348. 49 indexed citations

11.

Webb, Thomas R., Hiroaki Mitsuya, & Samuel Broder. (1988). 1-(2,3-Anhydro-.beta.-D-lyxofuranosyl)cytosine derivatives as potential inhibitors of the human immunodeficiency virus. Journal of Medicinal Chemistry. 31(7). 1475–1479. 61 indexed citations

12.

Matsushita, Shuzo, M Robert-Guroff, Jane B. Trepel, et al.. (1986). Human monoclonal antibody directed against an envelope glycoprotein of human T-cell leukemia virus type I.. Proceedings of the National Academy of Sciences. 83(8). 2672–2676. 58 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact